African Trypanosomiasis, also known as sleeping sickness, is a parasitic disease prevalent in sub-Saharan Africa, caused by protozoan parasites of the genus Trypanosoma. Two subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, are responsible for causing the disease in humans. The parasites are transmitted through the bite of infected tsetse flies. The initial symptoms of African Trypanosomiasis include fever, headaches, and joint pains, progressing to neurological symptoms as the parasites invade the central nervous system. If not addressed, the illness can lead to a fatal outcome. The severity of symptoms and the course of the illness depend on the subspecies of the parasite. Control and prevention strategies include vector control, surveillance, and early diagnosis and treatment. Challenges in managing the disease include limited healthcare infrastructure in affected regions, as well as the complex life cycle of the parasite and the adaptability of the tsetse fly vectors. Efforts are ongoing to develop new drugs and vaccines, and international collaboration is crucial for addressing the socio-economic factors contributing to the persistence of African Trypanosomiasis in affected communities.
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change & increasing pollution and respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Climate change & increasing tickborne illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Invasive group A streptococcal infections in children: Current therapeutic challenges
Elena Chiappini, University of Florence, Italy
Title : Global and regional routine pertussis vaccination coverage and anti-pertussis herd immunity levels in 2024, and variation from 2019 to 2024
Pedro Plans Rubio, College of Physicians of Barcelona, Spain